A 24‐year‐old patient with relapsed high‐risk T‐ALL (PTEN gene deletion; NOTCH1 mutation), was treated with the NOTCH inhibitor CB‐103. The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.